Sign in
4

Changes in Ownership

PMV Pharmaceuticals, Inc. Filed Acc 0001209191-20-052336

Director acquired 2,528,290 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Schroeder Thilo Director 2020-09-29 Conversion +1,768,023 1,768,023 I: show line 1 in the form
Schroeder Thilo Director 2020-09-29 Conversion +760,267 2,528,290 I: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Schroeder Thilo Director 2020-09-29 Conversion · Series C Preferred Stock −1,768,023 0 I: show line 3 in the form
Schroeder Thilo Director 2020-09-29 Conversion · Series D Preferred Stock −760,267 0 I: show line 4 in the form
Loading xslF345X03/doc4.xml…